HLB PANAGENE Co., LTD.

046210 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩1,174.00
+2.26%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.28.
  • Current assets comfortably cover current liabilities (current ratio 2.26).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -2.2 times.
  • Return on equity is on the lower side at -4.3%.
  • Return on capital employed is on the lower side at -4.6%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.36

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩534억
Current Price₩ 1,174.00
High / Low₩ 2,940.00 / 980.00
Stock P/E-16.77
Book Value₩ 1,591.13
ROCE-4.63%
ROE-4.32%
Debt to Equity0.28
Current Ratio2.26
EPS₩ -70.00
PAT Margin-20.77%
ICR-2.16
Educational data only. Not a recommendation to buy, sell or hold any security.